drugset / Trial / NCT02216045
Effect of Camel Milk on Chronic Hepatitis C
RandomizedParallel-groupOpen-labelTreatment
Summary
Camel milk as the new modality for treatment of chronic hepatitis C. The purpose of this study is to evaluate effectiveness and safety of camel milk in combination with Peginterferon Alfa-2a and Ribavirin in genotype 2,3 chronic hepatitis C virus .
Timeline
- Start
- 2014-06
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | camel milk | Unknown | 250 ml | Oral |
| Background | Peginterferon | Protein / enzyme biologic | 180 ug | Subcutaneous |
| Background | Ribavirin | Small molecule | 1000 mg | Oral |
| Background | Ribavirin | Small molecule | 1200 mg | Oral |